Lysine modification of human serum albumin and its effect on protein conformation and nalidixic acid binding

2021 ◽  
Vol 98 (3) ◽  
pp. 100031
Author(s):  
Cheau Yuaan Tan ◽  
Chun Shen Lim ◽  
Siew Mun Liew ◽  
Adyani Azizah Abd Halim ◽  
Saad Tayyab
2005 ◽  
Vol 71 (8) ◽  
pp. 4359-4363 ◽  
Author(s):  
Tiziana Lodi ◽  
Barbara Neglia ◽  
Claudia Donnini

ABSTRACT The control of protein conformation during translocation through the endoplasmic reticulum is often a bottleneck for heterologous protein production. The core pathway of the oxidative folding machinery includes two conserved proteins: Pdi1p and Ero1p. We increased the dosage of the genes encoding these proteins in the yeast Kluyveromyces lactis and evaluated the secretion of heterologous proteins. KlERO1, an orthologue of Saccharomyces cerevisiae ERO1, was cloned by functional complementation of the ts phenotype of an Scero1 mutant. The expression of KlERO1 was induced by treatment of the cells with dithiothreitol and by overexpression of human serum albumin (HSA), a disulfide bond-rich protein. Duplication of either PDI1 or ERO1 led to a similar increase in HSA yield. Duplication of both genes accelerated the secretion of HSA and improved cell growth rate and yield. Increasing the dosage of KlERO1 did not affect the production of human interleukin 1β, a protein that has no disulfide bridges. The results confirm that the ERO1 genes of S. cerevisiae and K. lactis are functionally similar even though portions of their coding sequence are quite different and the phenotypes of mutants overexpressing the genes differ. The marked effects of KlERO1 copy number on the expression of heterologous proteins with a high number of disulfide bridges suggests that control of KlERO1 and KlPDI1 is important for the production of high levels of heterologous proteins of this type.


2016 ◽  
Vol 192 ◽  
pp. 178-187 ◽  
Author(s):  
Xin Peng ◽  
Xiangchao Wang ◽  
Wei Qi ◽  
Rongxin Su ◽  
Zhimin He

Author(s):  
Rajagopal Subramanyam ◽  
Anilkishor Gollapudi ◽  
Persis Bonigala ◽  
Madhurarekha Chinnaboina ◽  
Damu G. Amooru

1980 ◽  
Vol 191 (1) ◽  
pp. 281-283 ◽  
Author(s):  
R G Reed ◽  
T Peters ◽  
S O Brennan ◽  
R W Carrell

Proalbumin Christchurch, a circulating variant of human serum albumin, is secreted from the liver without cleavage of the hexapeptide situated at the N-terminal end of the peptide chain of proalbumin. We compared ligand-binding properties of proalbumin Christchurch and of normal albumin A from the same individual in order to test the effect of the presence of the hexapeptide. The two albumin forms exhibited similar affinities for palmitate, bilirubin, 8-anilinonaphthalene-1-sulphonate and Bromocresol Green. The patterns of endogenous fatty acids bound to the two forms of albumin were slightly different, although the differences were probably not of physiological significance. From these studies it would appear that the propeptide of proalbumin does not alter the protein conformation in such a way as to alter binding sites for organic anions.


2017 ◽  
Vol 16 (12) ◽  
pp. 1762-1770 ◽  
Author(s):  
P. Sarbadhikary ◽  
A. Dube

An iodinated chlorin p6 copper complex showed high affinity to bind human serum albumin, the binding site was predicted and it was demonstrated that binding did not affect protein conformation.


1999 ◽  
Vol 26 (2-3) ◽  
pp. 173-180 ◽  
Author(s):  
Saad Tayyab ◽  
Soghra K. Haq ◽  
Sabeeha ◽  
Mohammad A. Aziz ◽  
Mohammad M. Khan ◽  
...  

2021 ◽  
Vol 12 (2) ◽  
pp. 1520-1525

Nalidixic acid (NA) is a quinolone drug used to treat urinary tract infections. It inhibits bacterial gyrase-DNA complex formation, an essential step for DNA supercoiling during bacterial replication. Due to the medical application of this drug, it would be interesting to get insight into its binding mechanism with human serum albumin (HSA), the primary carrier protein in blood circulation. Two reports of NA binding to HSA were published using molecular docking approaches. The first report revealed that the preferred binding site of NA was Site II of serum albumins, while the recent finding predicted Site I of bovine serum albumin (BSA) as the preferred site. Given the high sequence homology between these albumins, it is presumed that the binding preference of this drug should be the same in these proteins. To re-investigate this phenomenon, the interaction of NA with HSA was conducted using AutoDockTool 4.0. The molecular docking results revealed that NA binding preference was at Site I, involving Lys 199 in HSA, due to the formation of more significant contacts. Hence, it is concluded that any variable or parameters in the software should be wisely standardized to minimize the controversial results using different programs.


2013 ◽  
Vol 15 (1) ◽  
Author(s):  
Emilio I. Alarcon ◽  
Carlos J. Bueno-Alejo ◽  
Christopher W. Noel ◽  
Kevin G. Stamplecoskie ◽  
Natalia L. Pacioni ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document